Floatz logo

PROPRANOLOL

Diabetes Mellitus, Type 2

Turkish Metabolic Surgery FoundationSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

51 Active assets in the Diabetes Mellitus, Type 2 cohort.

Asset / SponsorPhaseRating
Metformin
Myopharm Limited
Phase 4BBB
Letrozole
ARKAY Therapeutics
Phase 4BBB
Vildagliptin
Al-Azhar University
Phase 4BBB
GLICLAZIDE
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4BBB
Humulin R
University of Aarhus
Phase 4BB

View all 50 →

Same molecule, other indications

PROPRANOLOL is also rated in:

migraine disorderDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varices with bleedingDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →